Axant

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Axant

What is Axant? Overview

Property Description
Active Ingredient Lactulose
Form Oral solution (Syrup)
Pharmacological Class Osmotic Laxative
General Purpose Facilitates easier bowel movements
Origin Synthetic disaccharide

What is Axant and What Type of Medicine is it?

Axant is the brand name for a pharmaceutical product whose single active ingredient is Lactulose, a derivative sugar molecule. It is classified as an osmotic laxative, a specific pharmacological class of agents that has been clinically recognized for managing conditions characterized by infrequent bowel movements. As a commercially available product, Axant is typically positioned as a reliable, gentle method for facilitating stool passage.

This classification is crucial because it immediately defines the drug's mechanism, separating it from stimulant laxatives. Axant is defined as a non-systemic, single-ingredient oral preparation, characterized by minimal absorption into the bloodstream. Its overall purpose is to support normal bowel function through a physical, localized effect.


Composition, Form, and Unique Positioning

Lactulose, the core component, is a synthetic disaccharide created through chemical synthesis from simpler sugars. Axant is supplied as an oral solution, commonly recognized as a viscous syrup. This formulation is often chosen to enhance patient compliance, particularly for those who find tablets difficult to swallow. The drug's defining characteristic is that it is a non-absorbable sugar; human enzymes in the small intestine are unable to break it down.

This purposeful structure ensures the active ingredient remains largely intact as it travels through the upper digestive tract. By design, the medicine primarily works where it is needed—in the colon—without entering the systemic circulation.


How Does Axant Generally Help?

The general purpose of Axant is to promote the passage of intestinal contents by improving their physical consistency. Its effect is based on a powerful osmotic principle: drawing and retaining water within the colon.

The retained water serves to both substantially soften the stool mass and increase its overall volume. By addressing both the consistency and bulk of the contents, Axant facilitates easier and more regular stool passage, providing gentle assistance in a typical use scenario where an individual is experiencing difficult or infrequent defecation.

Regulatory References

  1. Lactulose: MedlinePlus Drug Information
  2. Lactulose: StatPearls - NCBI Bookshelf - NIH

What side effects are possible with Axant?

Possible Side Effects and Safety Information

The safety profile for Axant (Lactulose) is documented based on official regulatory classifications, which primarily focus on effects within the Gastrointestinal disorders system. The frequency of documented adverse reactions is classified according to official regulatory standards.

Frequency Category Documented Adverse Reactions (SOC)
Very Common (ge 1/10) Diarrhoea
Common (ge 1/100 to < 1/10) Flatulence, Abdominal pain, Nausea, Vomiting
Uncommon (ge 1/1,000 to < 1/100) Electrolyte imbalance (due to diarrhoea)
Not Known (Post-marketing) Hypersensitivity reactions (e.g., Rash, Pruritus, Urticaria)

Safety Patterns and Restrictions

Adverse reactions involving fluid and electrolyte disturbances, such as Hypokalemia and Hypernatremia, are classified as serious adverse reactions when resulting from severe or excessive diarrhoea, typically associated with high-dose or long-term exposure. The official labeling notes that flatulence is an expected symptom that may appear during the first few days of use.

Specific safety constraints are documented for the use of Axant. The medicine is contraindicated in patients with Galactosaemia, as well as those experiencing gastro-intestinal obstruction or at risk of digestive perforation. Official safety notes advise caution for patients prone to electrolyte disorders and for diabetics, particularly when high doses are administered for extended periods. Use in infants is specified as exceptional and requires medical supervision.

Overdose and Emergency Response

Overdose and When to Seek Help

The regulatory documents define the overdose profile of Axant by the risk of Central Nervous System (CNS) depression, which presents with symptoms such as progressive sedation, drowsiness, and hypnosis. Severe outcomes include documented fatalities, particularly when the product is taken at doses higher than recommended or in combination with substances like alcohol or certain antidepressants. Overdose may also lead to Serotonin Syndrome, a potentially life-threatening condition characterized by neurological signs including agitation, confusion, muscle rigidity, and hyperthermia. Gastrointestinal symptoms such as nausea, vomiting, and diarrhea may also occur.

Official government guidance requires emergency medical attention to be sought immediately for severe manifestations. Regulators instruct that emergency services (911) must be contacted if the affected individual has collapsed, experiences a seizure, has trouble breathing, or cannot be awakened. Furthermore, the drug should be discontinued if Serotonin Syndrome is suspected.

The management of overdose consists of supportive therapy and procedural measures such as gastric lavage. Regulatory agencies mandate close monitoring for signs of respiratory depression and sedation. Population-specific considerations note that elderly patients may be especially susceptible to severe CNS depression.

Therapeutic Uses of Axant

Axant (typically a combination of a muscle relaxant and an NSAID) is primarily used as an adjunct therapy for symptoms related to physical discomfort associated with conditions involving episodic or fluctuating manifestations. This includes common ailments like muscle strains, sprains, and injuries.

The core therapeutic area is reflected in the indications for the muscle relaxant component, metaxalone, which is indicated as an adjunct to rest and physical therapy for these types of ailments. The combination of active components is commonly used to help with discomfort that involves both pain and muscle tension. Specifically, it helps with symptoms of increased neurological or muscular activity, such as tension and spasms, and is applied in addressing symptoms related to inflammatory or irritative states and physical discomfort. This medication contributes to improved comfort during periods of heightened symptoms and assists with maintaining functional stability during **episodes of heightened discomfort.


Quick Fact: Axant may assist with managing acute muscle spasms and physical discomfort.


Eligibility and Restrictions for Use

Who Can and Cannot Use Axant?

This section defines the official population eligibility rules for Axant (Metaxalone) based strictly on government regulatory documents, outlining who may use the medicine and who is prohibited from using it.


Official Eligibility Status

Classification Population or Condition Status as Stated in Label
Adult Use Adults Allowed
Pediatric Use Patients 13 years of age and older Allowed
Not Established Children 12 years of age or younger Safety and effectiveness not established
Contraindicated Known Hypersensitivity to components Prohibited
Contraindicated Severe Hepatic or Severe Renal Impairment Prohibited
Contraindicated Tendency toward Drug-Induced or Hemolytic Anemias Prohibited

Restrictions and Special Considerations

Axant is subject to additional usage restrictions defined by regulatory authorities.

  • Mild to Moderate Organ Impairment: Use requires great care and consideration for additional monitoring in patients with pre-existing mild to moderate liver or kidney impairment.
  • Geriatric Patients: Older adults may exhibit special susceptibility to Central Nervous System (CNS) effects, necessitating caution.
  • Pregnancy and Lactation: Safe use during pregnancy has not been established; the drug is generally not recommended for women who are or may become pregnant, or for nursing mothers.

What should I know about interactions with other medicines?

The official interaction profile for Axant focuses on the documented risk of additive pharmacodynamic effects and altered pharmacokinetic clearance.

Co-administration with Central Nervous System (CNS) Depressants, a category that includes alcohol, is officially documented to result in additive pharmacologic effects, leading to an increased risk of sedation. Furthermore, a highly significant pharmacodynamic interaction is noted with serotonergic drugs, where co-administration has been associated in regulatory reports with cases of Serotonin Syndrome.

From a pharmacokinetic perspective, the drug's overall bioavailability (Cmax and AUC) is increased when administered with food, a documented drug-food interaction that leads to higher systemic exposure. Clearance occurs primarily through hepatic oxidation, indicating that the co-administration of CYP enzyme inhibitors or inducers may formally alter the resulting plasma concentrations.

Regulatory documents impose constraints on use in compromised populations. Axant is contraindicated in patients with known severe hepatic impairment or severe renal impairment because the inability to safely clear the drug substantially increases potential exposure and interaction severity. Geriatric patients are also noted to be more susceptible to the additive effects of CNS depression.

Mechanism of Action

Activation by Colonic Microflora

The mechanism initiates when the Lactulose molecule, which resists digestion by human enzymes in the small intestine, reaches the colon intact. Here, it acts as a substrate for saccharolytic colonic bacteria . These bacteria metabolize Lactulose into various short-chain fatty acids (SCFAs). The conversion establishes a chemical change that initiates the subsequent physiological effects, including a drop in local pH and a resulting mild stimulation of colonic smooth muscle activity.


Osmotic Gradient and Fluid Dynamics

The SCFAs and any remaining unfermented Lactulose molecules collectively establish a significant osmotic gradient within the colon lumen. This concentration difference actively draws and retains a large volume of water from the intestinal lining into the fecal contents. The resulting physiological change—substantially softened consistency and increased stool bulk—modifies the physical properties of the intestinal contents. Because this entire cascade is dependent on intestinal transit and bacterial metabolism, the full generation of the core physiological changes requires a duration of 24 to 48 hours.

Dosage and Administration Information

How to Use Axant: Administration Guidelines

The principles for using Axant (Metaxalone) are based on standard instructions for its proper, short-term application. The medication is always administered via the oral route as an immediate-release tablet.

The medication is intended for acute use as an adjunct to rest and physical therapy, establishing its role as a supportive measure rather than a long-term primary treatment.


Dosing and Frequency

Feature Guideline
Standard Adult Dose 800 mg per dose.
Maximum Daily Limit 3200 mg over a 24-hour period.
Dosing Frequency The dose is taken three to four times a day.

Administration Contexts

Feature Guideline
Timing Relative to Meals May be taken with or without food. Consistency is advised, as food can significantly impact the drug's absorption.
Age-Group Rule The standard adult dosage applies to patients who are 13 years of age and older.
Missed Dose If a dose is missed, it should be taken as soon as possible, but the missed dose should be skipped if it is near the time for the next scheduled dose.
Procedural Restriction The 800 mg tablet is not interchangeable with the 640 mg tablet on a milligram-to-milligram basis.

This structured approach to dosing and frequency, along with the specified administration context, outlines the parameters for using Axant.

Recent Clinical Evidence

Research Evidence / Overview of Studies


Phase 3 Clinical Trials

Phase 3 studies represent the final stage of large-scale investigation before a treatment is reviewed by regulatory bodies. Research investigated the drug's properties, including its potential role in influencing a specific enzyme to see whether study participants displayed changes in inflammatory markers.

  • Research was conducted to evaluate outcomes associated with the compound in the context of chronic symptom management.
  • Studies examined whether the overall frequency of flare-ups changed during the trial period.
  • The primary outcome measure was the assessment of symptomatic changes over a period of 12 weeks.

Evaluating Specific Symptom Endpoints

Research explored the data gathered across several key symptomatic areas.

Joint Function and Mobility

Studies were primarily focused on the compound's use in the context of joint symptoms.

  • Research explored whether pain scores changed within the first week of use.
  • The research team investigated changes observed in joint function.
  • Findings were also used to measure whether swelling changed over time compared to placebo groups.

Combination Therapy Research

Some trials also examined the compound when used alongside existing established treatments.

  • Studies investigated whether mobility changed when the combination was used in patients with advanced conditions.
  • Safety and tolerability were documented across various adult patient populations in clinical studies involving both monotherapy and combination therapy approaches.

Non-Clinical and Early-Phase Research

The foundational research focused on the properties of the compound and its activity in laboratory models. Research suggests the compound’s properties were the subject of several early-stage studies. Animal models were used to evaluate whether certain disease biomarkers changed in the presence of the compound. Further research is necessary to fully understand the compound's long-term effects. Available evidence remains limited regarding its use in pediatric populations.

Frequently Asked Questions (FAQ)

Common questions about Axant (FAQ)


Q: Can Axant be taken long-term?

A: Official product information supports the use of Lactulose (the active ingredient in Axant) for chronic constipation. However, official guidelines advise that elderly or weakened patients receiving treatment for more than six months should have their serum electrolytes (body salts) checked periodically. Patients should follow the specific guidance provided by their healthcare provider regarding the length of treatment.


Q: How long does Axant stay in your system after stopping it?

A: Axant's active ingredient, Lactulose, is designed to be poorly absorbed, meaning very little of the medicine enters the bloodstream from the gut. The small amount that does get absorbed is quickly cleared by the body, typically within about 24 hours.


Q: Does Axant have any known effects on sleep patterns?

A: Official labeling does not list specific sleep pattern changes, but post-marketing reports indicate that confusion and restlessness have occurred in some individuals. These effects have an unknown frequency, meaning they are not common or common enough to be precisely measured in clinical trials. If unusual side effects, including those affecting sleep, are noticed, this should be discussed with a healthcare professional.


Q: Is Axant a controlled substance or habit-forming?

A: Axant (Lactulose solution) is an osmotic laxative and is not classified as a controlled substance by the US Drug Enforcement Administration (DEA). The medicine is not known to be habit-forming.


Q: What are the ingredients in Axant besides the main active component?

A: Axant is an oral solution whose active component is Lactulose. The final solution includes small amounts of sugars like galactose and lactose, as well as purified water, coloring agents (FD&C Yellow No. 6), flavoring, and sodium hydroxide used for pH balancing.


Q: How should Axant be stored at home?

A: Axant should be stored in a tightly closed container at room temperature, away from moisture, excessive heat, and direct light. It is important to prevent the solution from freezing, as this can cause the liquid to thicken. If the solution darkens slightly over time, the official labeling notes this is a normal occurrence.


Q: Is it normal to feel a little dizzy when first starting Axant?

A: Dizziness and lightheadedness have been reported as possible side effects, although the frequency is considered 'not known' from controlled studies, suggesting they are uncommon. If persistent or severe dizziness or lightheadedness occurs, it is appropriate to discuss this with a healthcare provider.


Q: Can I take other supplements or vitamins with Axant?

A: Official product information advises against taking other laxatives or antacids at the same time as Axant. The official product information does not list specific moderate or severe interactions with vitamins or common supplements. However, it is important for a patient’s healthcare provider to be aware of all supplements and medications being taken.


Q: Do many people experience a rash or skin irritation from Axant?

A: Rash, itching, and hives are signs of a possible hypersensitivity (allergic) reaction to the medicine. These reactions have been reported in post-marketing use, but their frequency is classified as 'not known,' meaning they are not common side effects.


Q: What are the documented benefits of taking Axant?

A: Clinical studies have shown that Axant is effective in treating constipation. The documented benefits include increasing the overall number of daily bowel movements and increasing the number of days on which bowel movements occur, helping to establish better regularity.


Q: Does Axant have a generic version available?

A: Yes, regulatory information shows that Lactulose solution is available through the Abbreviated New Drug Application (ANDA) pathway, which is the regulatory process for approving generic drugs in the US.


Q: Are there common mental or mood changes associated with Axant?

A: Mental or mood changes such as confusion, irritability, and restlessness have been reported as side effects. Their frequency is classified as 'not known,' suggesting they are uncommon. Any unusual mental or mood changes should be reported to a healthcare provider.


Q: Is it okay to drive or operate machinery while taking Axant?

A: Because some individuals have reported side effects like dizziness and confusion, caution is advised when driving or operating heavy machinery. Patients are advised to monitor their response to the medicine before engaging in activities that require focus and coordination, such as driving or operating machinery.


Q: Are there specific symptoms that indicate Axant is working?

A: The mechanism of Axant is to draw water into the colon, which softens the stool and increases its bulk. This change in stool consistency, along with easier and more frequent bowel movements, is typically how the medicine's effect is observed.


Q: Can Axant cause dry mouth or changes in taste?

A: Dry mouth has been reported as a possible side effect in some post-marketing data. This symptom has an 'unknown' frequency, meaning it is not considered a common event, but it may occur.


Q: What should I do if the side effects of Axant feel too strong?

A: If you experience severe or unusual side effects, such as unusual diarrhea, or if you feel any side effects are too strong or concerning, patients are advised to seek guidance from a healthcare professional.


Q: How long does a typical course of Axant treatment last?

A: Axant is indicated for chronic constipation, but the length of time the medicine is taken depends on the medical problem for which it is prescribed. A healthcare provider determines the appropriate duration based on individual needs.


Q: Do I need regular blood tests while taking Axant?

A: Regulatory information advises that patients who are elderly, frail, or debilitated and who receive Lactulose treatment for longer than six months should have their serum electrolytes—such as potassium and chloride—measured periodically to monitor for potential imbalance.


Q: Is there a recommended time of day to take Axant?

A: The medicine can be taken at any time of day and is often taken in divided doses (several times daily). One common practice is to take a dose at bedtime. A healthcare provider determines the appropriate duration, timing, and frequency based on individual needs.


Q: How often do people need to adjust their Axant dosage?

A: The official instructions indicate that the dose should be adjusted (titrated) based on the patient's clinical response. The goal of dosage adjustment is typically to achieve the desired effect of two to three soft stools daily.


Q: Does Axant affect fertility or pregnancy planning?

A: Official documents state that limited data suggests there are no harmful effects on pregnancy, and the drug may be used if medically necessary. Information on whether the active ingredient is passed into breast milk is not known, and there is no specific data available in the regulatory label concerning effects on fertility.


Q: What kind of studies support the claims made about Axant's benefits?

A: The claims about Axant's effectiveness are supported by clinical studies. These studies demonstrated that the product successfully increased the number of days with bowel movements and the total number of bowel movements in patients dealing with chronic constipation.


Q: Does Axant interact with common over-the-counter pain relievers?

A: The official product information does not list any severe or serious interactions with common non-prescription pain relievers. It is important for patients to discuss all medications with a healthcare professional before combining them.


Q: Can Axant be crushed or split if it's a tablet?

A: Axant is supplied as an oral solution (a syrup) and not as a solid tablet. Therefore, the question of crushing or splitting is not applicable to this form of the medicine.


Q: Is Axant safe for people with pre-existing heart conditions?

A: The use of Axant should be considered carefully in patients who are susceptible to electrolyte abnormalities. Severe diarrhea, which is a common side effect, can lead to serious imbalances in body salts (like potassium and sodium) that can affect heart function.


Q: Is Axant suitable for people with diabetes?

A: Because Lactulose solution is a synthetic sugar and contains small amounts of other sugars (lactose and galactose), the official labeling states that it should be used with caution in patients with diabetes.

How should Axant be stored and disposed of?

Storage Conditions

Axant (metaxalone tablets) must be stored at Controlled Room Temperature, specifically between 20°C and 25°C (68°F and 77°F). It is required to keep the medication in the container it came in, ensuring the container is tightly closed to protect it from environmental factors. Storage must avoid areas with excessive heat or moisture.

Child Safety and Stability

This medication must be kept out of the sight and reach of children.

Outdated medicine or medicine that is no longer needed must be discarded safely to maintain product stability and household safety.

Disposal Instructions

Unused or expired Axant should not be disposed of in household trash without preparation, nor should it be flushed down the toilet, as the active ingredient is not on the FDA's flush list. The preferred method is to take the product to an official drug take-back program. If one is unavailable, the medication must be mixed with an undesirable substance, sealed in a bag or container, and placed in the trash.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Axant found in:

A-Z Index: